Enhanced transdermal delivery of 5-aminolevulinic acid and a dipeptide by iontophoresis
- PMID: 20665477
- DOI: 10.1002/bip.21520
Enhanced transdermal delivery of 5-aminolevulinic acid and a dipeptide by iontophoresis
Abstract
Poor skin permeability limits the application of peptides to the skin. Enhanced skin permeation could facilitate the development of new therapies for dermatologic and cosmeceutical applications. The aim of this study was to investigate the application of iontophoresis to the delivery of small peptide model compounds (5-aminolevulinic acid and L-alanine-L-tryptophan) across human skin. Under the conditions tested, iontophoresis increased the in vitro permeability coefficient of ALA.HCl across human epidermis from 7 X 10(-5) cm/h with passive diffusion to 110 x 10(-5) cm/h with iontophoresis. D-Glucose permeation elucidated the iontophoretic electrotransport of ALA.HCl to have contributions of both electrorepulsion and electroosmosis. The L-alanine-L-tryptophan permeability coefficient was increased from 1.5 x 10(-5) cm/h to 35 x 10(-5) cm/h with iontophoretic application. Iontophoretic delivery of the dipeptide increased markedly at lower pH because of an increase in electrorepulsive transport. The study demonstrates that iontophoresis can enhance epidermal permeation of a small peptide and peptide-like drug by up to 15- and 22-fold under the conditions tested.
Similar articles
-
Enhanced transdermal delivery of a dipeptide by dermaportation.Biopolymers. 2008;90(5):655-62. doi: 10.1002/bip.21033. Biopolymers. 2008. PMID: 18536044
-
Cutaneous metabolism of a dipeptide influences the iontophoretic flux of a concomitant uncharged permeant.Int J Pharm. 2006 Jan 13;307(2):308-17. doi: 10.1016/j.ijpharm.2005.10.022. Epub 2005 Nov 28. Int J Pharm. 2006. PMID: 16310991
-
Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.Int J Pharm. 2007 Aug 16;341(1-2):114-24. doi: 10.1016/j.ijpharm.2007.04.004. Epub 2007 Apr 6. Int J Pharm. 2007. PMID: 17502130
-
Transscleral passive and iontophoretic transport: theory and analysis.Expert Opin Drug Deliv. 2018 Mar;15(3):283-299. doi: 10.1080/17425247.2018.1406918. Epub 2017 Dec 5. Expert Opin Drug Deliv. 2018. PMID: 29149574 Review.
-
An analysis of solute structure-human epidermal transport relationships in epidermal iontophoresis using the ionic mobility: pore model.J Control Release. 1999 Apr 19;58(3):323-33. doi: 10.1016/s0168-3659(98)00172-2. J Control Release. 1999. PMID: 10099157 Review.
Cited by
-
Cyclic Dipeptide Shuttles as a Novel Skin Penetration Enhancement Approach: Preliminary Evaluation with Diclofenac.PLoS One. 2016 Aug 22;11(8):e0160973. doi: 10.1371/journal.pone.0160973. eCollection 2016. PLoS One. 2016. PMID: 27548780 Free PMC article.
-
Nanoemulsions and nanoparticles for non-melanoma skin cancer: effects of lipid materials.Clin Transl Oncol. 2013 Jun;15(6):417-24. doi: 10.1007/s12094-012-0982-0. Epub 2013 Jan 24. Clin Transl Oncol. 2013. PMID: 23344664
-
Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery.Heliyon. 2022 Feb 11;8(2):e08938. doi: 10.1016/j.heliyon.2022.e08938. eCollection 2022 Feb. Heliyon. 2022. PMID: 35198788 Free PMC article. Review.
-
Iontophoresis Improved Growth Reduction of Invasive Squamous Cell Carcinoma in Topical Photodynamic Therapy.PLoS One. 2016 Jan 11;11(1):e0145922. doi: 10.1371/journal.pone.0145922. eCollection 2016. PLoS One. 2016. PMID: 26752697 Free PMC article.
-
Characterisation of the Molecular Mechanism of Permeation of the Prodrug Me-5ALA across the Human Stratum Corneum Using Molecular Dynamics Simulations.Int J Mol Sci. 2022 Dec 15;23(24):16001. doi: 10.3390/ijms232416001. Int J Mol Sci. 2022. PMID: 36555643 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources